Early Phase Solutions
Summary: Explore how you can leverage Catalent’s successful track record optimizing thousands of molecules, deep development expertise and broadest set of superior technologies to…
Optimizing Lipid-Based Formulation for Commercial Success
Summary: This 90-minute virtual workshop includes presentations from BASF and Catalent that demonstrate on how lipid-based drug softgel technology can provide formulators with an effective delivery…
All Offerings
Summary: Catalyst + Talent. Our name combines these ideas. From drug and biologic development to delivery technologies and supply solutions, we are the catalyst for your…
Regulatory Support
Summary: Our regulatory team completes over 150 agency submissions each year, supporting all stages of the product lifecycle. We assign a dedicated…
Catalent: Softgel Encapsulation
Summary: Softgel technology is the commercially-proven choice for encapsulation of challenging compounds. In addition, softgel technology may enhance the bioavailability of your product to…
Improving Bioavailability with Softgel Technology
Summary: Softgel technology offers a number of technical benefits. Probably foremost is the improvement or enhanced bioavailability that’s often achievable with the Softgel dosage…
RP Scherer Softgel Technology for Superior Drug Delivery
Summary: As innovators of softgel technology, Catalent RP Scherer softgel brings more than 75 years of development expertise and manufacturing experience to the full spectrum of drug delivery…
How to Effectively Work with a Development Partner – From a Consultant Standpoint
Summary: Determining a client’s primary goal is critical to guiding them through the development of their asset. Three experienced industry colleagues recently presented on the latest tips…
RP Scherer Softgel Technology | Why Catalent?
Summary: As innovators of softgel technology, Catalent RP Scherer softgel, brings more than 75 years of development expertise and manufacturing experience to the full spectrum…
RP Scherer Softgel Heritage | Why Catalent?
Summary: As innovators of softgel technology, Catalent RP Scherer softgel brings more than 75 years of development expertise and manufacturing experience to the full spectrum of drug…
Reliably Supplied | Why Catalent?
Summary: We have the technology and expertise to take your product from design, to clinical trial, to plant, to pharmacy. Our global network of facilities can provide scalable, cost-effective…
Softgel Technology to Deliver Poorly Soluble APIs | Catalent in 90 Seconds
Summary: The number of poorly soluble new drugs entering development has been estimated to be anywhere from 40% to 70%. Many companies are increasingly focusing their attention on the properties…
OptiShell Technology Solves Bioavailability Challenges | Catalent in 90 Seconds
Summary: OptiShell™ capsules utilize a patented shell derived from plant polysaccharides that are ideally suited for the encapsulation of higher melting point fill formulations. Soft capsules containing semi-solid…
Catalent in 30 Seconds
Summary: With over 80 years serving the industry, Catalent is the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products….
Optimal Drug Delivery Technologies. Better Treatments.
Summary: We are your catalyst for creating better treatments. Our deep expertise in drug development, delivery and supply can help improve the bioavailability of your compound, enhance therapeutic profiles…
Catalent Corporate Overview
Summary: Catalent is the global leader in development, delivery, and supply for pharmaceuticals, biologics, and consumer health products. Integrated analytical and clinical supply services support to…
Unlock Your Molecules Potential with Catalent
Summary: Your molecule has so much potential, we share the passion to unlock it through extensive expertise and superior formulation technologies. Learn how we have optimized thousands…
Bring Pharma, Biopharma and Consumer Health Products to Market with Catalent
Summary: A short video on how Catalent can help you develop, deliver, supply better treatments. Whether it is Pharmaceuticals, Biopharmaceuticals, Over-the-Counter, Nutritionals or Beauty Care and Cosmetics, we can…
OptiForm® Solution Suite – Fast Track Early Development | Catalent in 90 Seconds
Summary: Learn about a Fast, Flexible and Fact-based path for your molecule to progress from late-stage discovery to phase I.
Softgel Encapsulation
Summary: Softgel technology is the commercially-proven choice for encapsulation of challenging compounds. In addition, softgel technology may enhance the bioavailability of your product to…
Career Development at Catalent
Summary: Catalent offers employees numerous opportunities for development and career progression. Hear more about what our team has to say about how Catalent supports their…
Product Development Careers at Catalent
Summary: Members of our product development eam gain unparalleled experience working on several products using multiple technologies. Hear what it’s like to work…
Expediting Path to Clinic with OptiForm® Total Supply
Summary: MGB Biopharma, a biotech company based in Scotland, U.K. was developing a new class of anti-infective medicine based on Minor Groove Binder compounds. Learn how Catalent provided integrated formulation…
De-Risk Your Early Phase Programs
Lipid based drug delivery systems (LBDDS) are the most studied and understood bioavailability enhancing solutions
Innovative OTC Remedies for the Seasonal Flu Epidemic
We will review the current OTC remedies for cough, cold and allergy categories and discuss strategies to grow your share on shelf space with innovative dosage forms.
Is Lipid Based Formulation Best for Your Molecule?
Watch this webinar to learn the key considerations for evaluating available technologies to find the most suitable bioavailability solution.
Using Lipid Based Delivery For Early Phase Development
Lipid-based drug delivery systems provide a reliable solution for poorly soluble molecules
The Truths and Myths of LBDDS
Clarifying the myths surrounding LBDSS which may make drug developers consider it in parallel to other formulation approaches
Overcome Bioavailability Challenges with Lipid Drug Delivery
How to apply lipid based formulation and encapsulate in softgel capsules for a poorly soluble molecule.
Optimizing Clinical Outcomes for Challenging Molecules
How lipid-based drug delivery systems (LBDDS) can be used as a bioavailability enhancing technology.
The Challenges in Developing Therapeutic Cannabis
Development of Cannabis- based drugs can offer a consistent, reliable dose with minimal side effects.
Pediatric Drug Delivery Challenges and Solutions
Key development challenges and promising technologies for delivering pediatric formulations.
Lipid Workshop Part 2: Expanding Lipid Formulation Platform
Latest softgel technology for targeted and controlled delivery of challenging molecules.
Lipid Workshop Part 1: Early Development With Lipids
Softgel technology for early development to achieve successful formulation and patient outcomes.
Softgel: Shapes and Sizes
Softgel technology has been increasingly applied across a wide range of applications including prescription medicines, consumer health, vitamins & mineral supplements and cosmetics.
The Soft Side of Drug Delivery
Discover an innovative way to deliver challenging and poorly soluble compounds.
OptiShell™ Technology for the OTC Market
Innovative solution for overcoming encapsulation challenges for OTC products.
LBDDS to Bring Poorly Soluble Drugs to Market
Address compounds early on in the development process to reduce costs & attrition rates.
Overcome Formulation Challenges & Gain Customer Acceptance
Enhance bioavailability, deliver liquid APIs & more with softgel technology.
Softgel Technologies to Deliver Poorly Soluble Molecules
Expedite the development pathway for early phase compounds and enhance bioavailability.
Catalent Innovations, Trends and New Technologies
Boost bioavailability, improve ease & route of administration, and increase patient compliance.
Enteric Coated Softgels for Consumer Products
Improve product performance & enhance consumer experience with enteric coating.
Softgel Capsules Low Batch Size Optimize in cGMP Labs
Handle small amounts of API or formulation at the early stages of development.
Optimization of Type I & II Lipid Based Drug Delivery System
Limit individual variability of type I & II systems with adequate choice of composition.
Solutions for Challenging Compounds Using Softgel Innovation
Improve compatibility with wider range of excipients to enhance bioavailability & stability.
The Versatility of Softgel Technology
Optimize manufacturing parameters like lower processing temperature & thinner softgel shell.
New Approaches for Macromolecule Oral Delivery
The toolkit of technologies based upon lipid-based drug delivery systems.
OptiGel Mini Technology
Deliver higher API concentrations in smaller capsules for patient benefits.
AAPS 2014 with Pharmaceutical Outsourcing
OptiPact™ Technology, capabilities for Orphan Drugs & Catalent’s factors of differentiation.
OptiGel Bio Enables Delivery of Synthetic Oligosaccharides
Macromolecules can potentially be converted from injectable to oral drug delivery.
Lipid-Based Delivery of Peptide Therapeutics
An explanation of OptiGel Bio™ technology as a delivery tool for macromolecule NCE candidates.
Conversion from LFHS to RP Scherer Softgel Capsules
RP Scherer Technology can improve timelines and commercialization potential.
OptiShell® Technology Capsule Innovations
New shell and hot-filling that are highly viscous or semi-solid at room temperature